UroGen Pharma Ltd. (FRA:UR8)
Germany · Delayed Price · Currency is EUR 17.30
+0.80 (4.85%)
Last updated: Jan 27, 2026, 8:07 AM CET
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of €772.62 million as of January 30, 2026. Its market cap has increased by 81.31% in one year.
Market Cap
772.62M
Enterprise Value
774.74M
Revenue
82.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
€17.30
Market Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from 152.95M to 772.62M, an increase of 405.15%. That is a compound annual growth rate of 20.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 772.62M | -17.25% |
| Dec 31, 2025 | 933.69M | 115.09% |
| Dec 31, 2024 | 434.10M | 3.64% |
| Dec 29, 2023 | 418.87M | 118.57% |
| Dec 30, 2022 | 191.64M | 2.22% |
| Dec 31, 2021 | 187.48M | -42.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 4, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| tonies SE | 1.18B |
| Sedlmayr Grund und Immobilien AG | 983.95M |
| Berliner Effektengesellschaft AG | 886.48M |
| Northern Data AG | 815.94M |
| Maschinenfabrik Berthold Hermle AG | 787.50M |
| Paul Hartmann AG | 777.83M |
| EUROKAI GmbH & Co. KGaA | 701.68M |
| FRoSTA Aktiengesellschaft | 656.73M |